475 related articles for article (PubMed ID: 23755826)
21. Assessment of risk of variant creutzfeldt-Jakob disease (vCJD) from use of bovine heparin.
Huang Y; Forshee RA; Keire D; Lee S; Gregori L; Asher DM; Bett C; Niland B; Brubaker SA; Anderson SA; Yang H
Pharmacoepidemiol Drug Saf; 2020 May; 29(5):575-581. PubMed ID: 32134162
[TBL] [Abstract][Full Text] [Related]
22. [Bovine spongiform encephalopathy and Creutzfeldt-Jakob disease. Current questions].
Brugère-Picoux J
Bull Acad Natl Med; 1996 Feb; 180(2):291-9; discussion 300-3. PubMed ID: 8705376
[TBL] [Abstract][Full Text] [Related]
23. Bovine spongiform encephalopathy and new variant Creutzfeldt-Jakob disease: an overview.
Patterson WJ; Painter MJ
Commun Dis Public Health; 1999 Jan; 2(1):5-13. PubMed ID: 10462888
[TBL] [Abstract][Full Text] [Related]
24. Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease: background, evolution, and current concerns.
Brown P; Will RG; Bradley R; Asher DM; Detwiler L
Emerg Infect Dis; 2001; 7(1):6-16. PubMed ID: 11266289
[TBL] [Abstract][Full Text] [Related]
25. Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease: a risk analysis.
Liberski PP
Folia Neuropathol; 2000; 38(4):143-50. PubMed ID: 11693716
[TBL] [Abstract][Full Text] [Related]
26. [Variant Creutzfeldt-Jakob disease in France: estimating the number of cases related to travel to the United Kingdom between 1980 and 1995].
Chadeau-Hyam M; Alpérovitch A
Rev Epidemiol Sante Publique; 2005 Feb; 53(1):15-24. PubMed ID: 15888987
[TBL] [Abstract][Full Text] [Related]
27. Prevalence in Britain of abnormal prion protein in human appendices before and after exposure to the cattle BSE epizootic.
Gill ON; Spencer Y; Richard-Loendt A; Kelly C; Brown D; Sinka K; Andrews N; Dabaghian R; Simmons M; Edwards P; Bellerby P; Everest DJ; McCall M; McCardle LM; Linehan J; Mead S; Hilton DA; Ironside JW; Brandner S
Acta Neuropathol; 2020 Jun; 139(6):965-976. PubMed ID: 32232565
[TBL] [Abstract][Full Text] [Related]
28. The new variant of Creutzfeldt-Jakob disease.
Zeidler M; Ironside JW
Rev Sci Tech; 2000 Apr; 19(1):98-120. PubMed ID: 11189730
[TBL] [Abstract][Full Text] [Related]
29. Sporadic Creutzfeldt-Jakob disease in the United Kingdom: analysis of epidemiological surveillance data for 1970-96.
Cousens SN; Zeidler M; Esmonde TF; De Silva R; Wilesmith JW; Smith PG; Will RG
BMJ; 1997 Aug; 315(7105):389-95. PubMed ID: 9277601
[TBL] [Abstract][Full Text] [Related]
30. Variant Creutzfeldt-Jakob disease.
Collinge J
Lancet; 1999 Jul; 354(9175):317-23. PubMed ID: 10440324
[TBL] [Abstract][Full Text] [Related]
31. Two unusual bovine spongiform encephalopathy cases detected in Great Britain.
Stack M; Focosi-Snyman R; Cawthraw S; Davis L; Jenkins R; Thorne L; Chaplin M; Everitt S; Saunders G; Terry L
Zoonoses Public Health; 2009 Aug; 56(6-7):376-83. PubMed ID: 19497088
[TBL] [Abstract][Full Text] [Related]
32. Predicting the size of the vCJD epidemic in France.
Alpérovitch A; Will RG
C R Biol; 2002 Jan; 325(1):33-6. PubMed ID: 11862620
[TBL] [Abstract][Full Text] [Related]
33. Consumers' understanding and concerns about bovine spongiform encephalopathy (BSE): comparison among Canadian, American, and Japanese consumers.
Muringai V; Goddard E; Aubeeluck A
J Toxicol Environ Health A; 2011; 74(22-24):1592-608. PubMed ID: 22043916
[TBL] [Abstract][Full Text] [Related]
34. Long-term subclinical carrier state precedes scrapie replication and adaptation in a resistant species: analogies to bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease in humans.
Race R; Raines A; Raymond GJ; Caughey B; Chesebro B
J Virol; 2001 Nov; 75(21):10106-12. PubMed ID: 11581378
[TBL] [Abstract][Full Text] [Related]
35. Variant Creutzfeldt-Jakob disease and bovine spongiform encephalopathy.
Belay ED; Schonberger LB
Clin Lab Med; 2002 Dec; 22(4):849-62, v-vi. PubMed ID: 12489284
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the neuropathological characteristics of bovine spongiform encephalopathy (BSE) and variant Creutzfeldt-Jakob disease (vCJD) in mice.
Brown DA; Bruce ME; Fraser JR
Neuropathol Appl Neurobiol; 2003 Jun; 29(3):262-72. PubMed ID: 12787323
[TBL] [Abstract][Full Text] [Related]
37. Pathogenesis and prevalence of variant Creutzfeldt-Jakob disease.
Hilton DA
J Pathol; 2006 Jan; 208(2):134-41. PubMed ID: 16362983
[TBL] [Abstract][Full Text] [Related]
38. Implications of BSE infection screening data for the scale of the British BSE epidemic and current European infection levels.
Donnelly CA; Ferguson NM; Ghani AC; Anderson RM
Proc Biol Sci; 2002 Nov; 269(1506):2179-90. PubMed ID: 12427310
[TBL] [Abstract][Full Text] [Related]
39. BSE and vCJD: causes, controls and concerns.
Vet Rec; 2000 Oct; 147(15):405-6. PubMed ID: 11072983
[No Abstract] [Full Text] [Related]
40. BSE and variant CJD: emerging science, public pressure and the vagaries of policy-making.
Hueston WD
Prev Vet Med; 2013 May; 109(3-4):179-84. PubMed ID: 23287715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
